2 Hrs
Source:
المشهد
المشهد
Ready to play
Ready to play
A recent study has shown that the use of glucosamine supplements, which are commonly used to treat joint pain, is associated with a 25% increase in the likelihood of developing dementia and experiencing cognitive decline, especially among patients who already have dementia. It was found that the effect of glucosamine was particularly significant in increasing the risk of death among those with dementia, based on an analysis of medical records from over 60,000 patients. The findings suggest that abnormal linkage of sugars with proteins in the brain may contribute to the deterioration of neural functions.
Notice: This Is an AI-Generated Summary
Comments (0)